Efficacy & Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis

PHASE3CompletedINTERVENTIONAL
Enrollment

787

Participants

Timeline

Start Date

June 30, 2019

Primary Completion Date

February 23, 2022

Study Completion Date

September 26, 2022

Conditions
Moderate-to-Severe Atopic Dermatitis
Interventions
DRUG

Placebo

Placebo

DRUG

Nemolizumab

Nemolizumab

Trial Locations (138)

159

Galderma Investigation Site 6228, Tbilisi

Galderma Investigational Site 6224, Tbilisi

Galderma Investigational Site 6235, Tbilisi

186

Galderma Investigational Site 6234, Tbilisi

1036

Galderma Investigational Site 6147, Budapest

1085

Galderma Investigational Site 5513, Budapest

1200

Galderma Investigational Site 5448, Brussels

1407

Galderma Investigational Site 6051, Sofia

1408

Galderma Investigational Site 6078, Sofia

1431

Galderma Investigational Site 6102, Sofia

Galderma Investigational Site 6165, Sofia

1528

Galderma Investigational Site 6216, Sofia

1606

Galderma Investigational Site 6046, Sofia

Galderma Investigational Site 6080, Sofia

1618

Galderma Investigational Site 6079, Sofia

1784

Galderma Investigational Site 6250, Sofia

2100

Galderma Investigational Site 6236, Zugdidi

3000

Galderma Investigational Site 6038, Leuven

4000

Galderma Investigational Site 6162, Liège

4025

Galderma Investigational Site 5567, Debrecen

4032

Galderma Investigational Site 6026, Debrecen

5700

Galderma Investigational Site 6254, Gyula

5800

Galderma Investigational Site 6029, Pleven

6000

Galderma Investigational Site 6251, Stara Zagora

6120

Galderma Investigational Site 6062, Halle

6200

Galderma Investigational Site 5140, Nice

7548

Galderma Investigational Site 5442, Gera

8200

Galderma Investigational Site 6053, Veszprém

9000

Galderma Investigational Site 6164, Ghent

10022

Galderma Investigational Site 8733, New York

10134

Galderma Investigational Site 6068, Tallinn

10138

Galderma Investigational Site 6069, Tallinn

13045

Galderma Investigational Site 8723, Cortland

13500

Galderma Investigational Site 6170, Martigues

14221

Galderma Investigational Site 8741, Buffalo

15213

Galderma Investigational Site 8721, Pittsburgh

20089

Galderma Investigational Site 6155, Rozzano

20251

Galderma Investigational Site 6041, Hamburg

20537

Galderma Investigational Site 6150, Hamburg

22391

Galderma Investigational Site 6040, Hamburg

23219

Galderma Investigational Site 8896, Richmond

24148

Galderma Investigational Site 6086, Kiel

26000

Galderma Investigational Site 6168, Valence

27100

Galderma Investigational Site 6180, Pavia

27408

Galderma Investigational Site 8823, Greensboro

27612

Galderma Investigational Site 8030, Raleigh

29420

Galderma Investigational Site 8713, North Charleston

31000

Galderma Investigational Site 6169, Toulouse

33013

Galderma Investigational Site 8391, Hialeah

33016

Galderma Investigational Site 8727, Hialeah

33125

Galderma Investigational Site 8719, Miami

33137

Galderma Investigational Site 8656, Miami

33155

Galderma Investigational Site 8704, Miami

33175

Galderma Investigational Site 8706, Miami

33484

Galderma Investigational Site 8875, Delray Beach

33607

Galderma Investigational Site 8203, Tampa

33615

Galderma Investigational Site 8839, Tampa

33770

Galderma Investigational Site 8523, Largo

35244

Galderma Investigational Site 8749, Birmingham

Galderma Investigational Site 8893, Birmingham

35976

Galderma Investigational Site 8866, Guntersville

36100

Galderma Investigational Site 6175, Vicenza

37075

Galderma Investigational Site 6081, Goettigen

37421

Galderma Investigational Site 8705, Chattanooga

40138

Galderma Investigational Site 6145, Bologna

40225

Galderma Investigational Site 6031, Düsseldorf

43124

Galderma Investigational Site 6151, Parma

44093

Galderma Investigational Site 6167, Nantes

45219

Galderma Investigational Site 8747, Cincinnati

47150

Galderma Investigational Site 8724, New Albany

48202

Galderma Investigational Site 8554, Detroit

50417

Galderma Investigational Site 6067, Tartu

52074

Galderma Investigational Site 5482, Aachen

53127

Galderma Investigational Site 6082, Bonn

55131

Galderma Investigational Site 6084, Mainz

56126

Galderma Investigational Site 6143, Pisa

59037

Galderma Investigational Site 5031, Lille

60008

Galderma Investigational Site 8729, Rolling Meadows

60437

Galderma Investigational Site 6083, Frankfurt

66013

Galderma Investigational Site 6141, Chieti

67100

Galderma Investigational Site 6045, L’Aquila

69120

Galderma Investigational Site 5469, Heidelberg

69495

Galderma Investigational Site 5407, Pierre-Bénite

72037

Galderma Investigational Site 6198, Le Mans

75015

Galderma Investigational Site 6133, Paris

75475

Galderma Investigational Site 6166, Paris

76710

Galderma Investigational Site 8618, Waco

77029

Galderma Investigational Site 8807, Houston

77598

Galderma Investigational Site 8003, Webster

80337

Galderma Investigational Site 5382, Munich

83800

Galderma Investigational Site 6197, Toulon

84117

Galderma Investigational Site 8672, Salt Lake City

85255

Galderma Investigational Site 8808, Scottsdale

86179

Galderma Investigational Site 5566, Augsburg

89106

Galderma Investigational Site 8825, Las Vegas

90033

Galderma Investigational Site 8683, Los Angeles

90201

Galderma Investigational Site 8906, Bell Gardens

91105

Galderma Investigational Site 8745, Pasadena

91304

Galderma Investigational Site 8905, Canoga Park

91762

Galderma Investigational Site 8799, Ontario

92024

Galderma Investigational Site 8577, Encinitas

92123

Galderma Investigational Site 8658, San Diego

92660

Galderma Investigational Site 8907, Newport Beach

92683

Galderma Investigational Site 8820, Westminster

92705

Galderma Investigational Site 8536, Santa Ana

92840

Galderma Investigational Site 8673, Garden Grove

97210

Galderma Investigational Site 8212, Portland

98105

Galderma Investigational Site 8434, Seattle

119228

Galderma Investigational Site 6124, Singapore

169608

Galderma Investigational Site 6077, Singapore

308205

Galderma Investigational Site 5499, Singapore

06030

Galderma Investigational Site 8637, Farmington

07601

Galderma Investigational Site 8506, Hackensack

29 107

Galderma Investigational Site 6135, Quimper

0159

Galderma Investigational Site 6238, Tbilisi

0186

Galderma Investigational Site 6227, Tbilisi

Galderma Investigational Site 6230, Tbilisi

01097

Galderma Investigational Site 6132, Dresden

00133

Galderma Investigational Site 6044, Roma

00168

Galderma Investigational Site 6049, Roma

00 144

Galderma Investigational Site 6177, Rome

15-453

Galderma Investigational Site 5773, Bialystok

41-500

Galderma Investigational Site 6097, Chorzów

40-611

Galderma Investigational Site 5021, Katowice

30-033

Galderma Investigational Site 5362, Krakow

31-559

Galderma Investigational Site 6052, Krakow

90-436

Galderma Investigational Site 5363, Lodz

20-080

Galderma Investigational Site 5367, Lublin

67-100

Galderma Investigational Site 5377, Nowa Sól

10-229

Galderma Investigational Site 6063, Olsztyn

60-529

Galderma Investigational Site 6085, Poznan

35-055

Galderma Investigational Site 5495, Rzeszów

71-434

Galderma Investigational Site 6130, Szczecin

33-100

Galderma Investigational Site 6048, Tarnów

01-142

Galderma Investigational Site 6126, Warsaw

01-817

Galderma Investigational Site 5707, Warsaw

50-566

Galderma Investigational Site 6185, Wroclaw

51-318

Galderma Investigational Site 6096, Wroclaw

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Galderma R&D

INDUSTRY